First drug to reduce 'suicide headaches' gets FDA approval

On Tuesday, the US Food and Drug Administration approved the self-injectable drug, Emgality, to reduce the number of headaches occur in 'clusters' that are mainly suffered by young men.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news